PLYX

Polaryx Therapeutics Inc

Feb 03 • 04:00PM ET

21.95

-13.05 -37.29 %

Healthcare • Biotechnology • USA • NASD

Today, 2:02 PMNegative market reaction to preclinical data announcement triggered sharp intraday decline.

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.17	Insider Own	-	Shs Outstand	47.34M	Perf Week	-
Market Cap	1.04B	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	1.03B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-8.21M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	0.00M	P/B	196.03	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-37.29%
Book/sh	0.11	P/C	180.72	EPS next 5Y	-	ROE	-	52W High	48.91 -55.12%	Perf Year	-
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	- -	ROIC	-154.93%	52W Low	20.00 9.75%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	23.60	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.77	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	8.77	EPS Q/Q	-85.28%	SMA20	-22.91%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-22.91%	Rel Volume	2.24	Prev Close	35.00
Employees	-	LT Debt/Eq	0.00	Earnings	-	SMA200	-22.91%	Avg Volume	25.93K	Price	21.95
IPO	Feb 02, 2026	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	58,147	Change	-37.29%

Today 08:30AM	Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium as Company Prepares for SOTERIA Trial Launch (GlobeNewswire) -37.29%
Feb-02-26 08:30AM	Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol "PLYX" (GlobeNewswire)

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.